Relevant bibliographies by topics / Nanocarrier systems

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Nanocarrier systems'

Author: Grafiati
Published: 2 June 2025
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Nanocarrier systems.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Nanocarrier systems"

1

Kang, Yunxiang, Sunxin Zhang, Guoqi Wang, et al. "Nanocarrier-Based Transdermal Drug Delivery Systems for Dermatological Therapy." Pharmaceutics 16, no. 11 (2024): 1384. http://dx.doi.org/10.3390/pharmaceutics16111384.

Full text
Abstract:
Dermatoses are among the most prevalent non-fatal conditions worldwide. Given this context, it is imperative to introduce safe and effective dermatological treatments to address the diverse needs and concerns of individuals. Transdermal delivery technology offers a promising alternative compared to traditional administration methods such as oral or injection routes. Therefore, this review focuses on the recent achievements of nanocarrier-based transdermal delivery technology for dermatological therapy, which summarizes diverse delivery strategies to enhance skin penetration using various nanoc
APA, Harvard, Vancouver, ISO, and other styles
2

Mukherjee, Soumajit, Zuzana Bytesnikova, Amir M. Ashrafi, Vojtech Adam, and Lukas Richtera. "Graphene Oxide as a Nanocarrier for Biochemical Molecules: Current Understanding and Trends." Processes 8, no. 12 (2020): 1636. http://dx.doi.org/10.3390/pr8121636.

Full text
Abstract:
The development of an advanced and efficient drug delivery system with significant improvement in its efficacy and enhanced therapeutic value is one of the critical challenges in modern medicinal biology. The integration of nanomaterial science with molecular and cellular biology has helped in the advancement and development of novel drug delivery nanocarrier systems with precision and decreased side effects. The design and synthesis of nanocarriers using graphene oxide (GO) have been rapidly growing over the past few years. Due to its remarkable physicochemical properties, GO has been extensi
APA, Harvard, Vancouver, ISO, and other styles
3

Mehanna, Mohammed M., and Kawthar K. Abla. "siRNA nanohybrid systems: false hope or feasible answer in cancer management." Therapeutic Delivery 13, no. 2 (2022): 109–33. http://dx.doi.org/10.4155/tde-2021-0068.

Full text
Abstract:
Finding out predisposition and makeup alterations in cancer cells has prompted the exploration of exogenous small interference RNA (siRNA) as a therapeutic agent to deal with cancer. siRNA is subjected to many limitations that hinder its cellular uptake. Various nanocarriers have been loaded with siRNA to improve their cellular transportation and have moved to clinical trials. However, many restrictions as low encapsulation efficiency, nanocarrier cytotoxicity and premature release of siRNA have impeded the single nanocarrier use. The realm of nanohybrid systems has emerged to overcome these l
APA, Harvard, Vancouver, ISO, and other styles
4

Suman, Sah Kanu, Patel Abhimanyu, Ojha Abhijeet, Jaswal Saloni, and Chaudhary Praveen. "Lipid-Based Nanocarrier as Bioactive Transporter for Peptide Delivery: A Recent Update." International Journal of Pharmacy and Biological Sciences-IJPBS 13, no. 2 (2023): 108–20. https://doi.org/10.5281/zenodo.8310384.

Full text
Abstract:
Lipid-based Nanocarriers are becoming popular nowadays because of their potential application in oral drug delivery systems having advantages like strong compatibility, and low toxicity. The bioactive molecules for nanocarrier drug delivery systems play a role in the promising treatment of diseases like urinary tract infection, dental problems, cancer, etc. To overcome the problem i.e., physical, and chemical unstability, various types of nanocarrier delivery systems that stabilize by using approaches of encapsulation technology are introduced. Lipid nanoparticles are stabilized by adding emul
APA, Harvard, Vancouver, ISO, and other styles
5

Jain, Dhara, Md Abdur Rashid, and Farhan J. Ahmad. "Recent Advances in Targeted Drug Delivery Approaches Using Lipidic and Polymeric Nanocarriers for the Management of Alzheimer’s Disease." Current Pharmaceutical Design 27, no. 43 (2021): 4388–403. http://dx.doi.org/10.2174/1381612827666210927163258.

Full text
Abstract:
: Drug delivery to the brain has been a significant challenge in treating neurodegenerative disorders such as Alzheimer's disease due to the presence of the blood-brain barrier, which primarily obstructs the access of drugs and biomolecules into the brain. Several methods to overcome the blood-brain barrier have been employed, such as chemical disruption, surgical intervention, focused ultrasound, intranasal delivery, and the use of nanocarriers. Nanocarrier systems remain the method of choice and have shown promising results over the past decade to achieve better drug targeting. Polymeric nan
APA, Harvard, Vancouver, ISO, and other styles
6

Werengowska-Ciećwierz, Karolina, Marek Wiśniewski, Artur P. Terzyk, and Sylwester Furmaniak. "The Chemistry of Bioconjugation in Nanoparticles-Based Drug Delivery System." Advances in Condensed Matter Physics 2015 (2015): 1–27. http://dx.doi.org/10.1155/2015/198175.

Full text
Abstract:
Nanomedicine is, generally, the application of nanotechnology to medicine. The term nanomedicine includes monitoring, construction of novel drug delivery systems, and any possible future applications of nanotechnology and nanovaccinology. In this review, the most important ligand-nanocarrier and drug-nanocarrier bioconjugations are described. The detailed characterizations of covalently formed bonds between targeted ligand and nanocarrier, including amide, thioether, disulfide, acetyl-hydrazone and polycyclic groups, are described. Also, the coupling of small elements and heteroatoms in the fo
APA, Harvard, Vancouver, ISO, and other styles
7

Kamal, Singh Rathore Jain Monal*. "Nanocarriers Revolutionizing Transdermal Drug Delivery: A Comprehensive Review of Recent Advances." International Journal of Pharmaceutical Sciences 2, no. 7 (2024): 1753–65. https://doi.org/10.5281/zenodo.12806579.

Full text
Abstract:
Nanocarrier-based transdermal drug delivery systems (TDDS) represent cutting-edge innovations in delivery methods, offering enhanced drug penetration through the skin, which serves as a significant barrier in traditional TDDS. This review aims to offer a comprehensive analysis of nanocarrier-based transdermal drug delivery systems (TDDS), focusing on their mechanisms, types, advantages, challenges, and future prospects. The primary objective is to highlight the key benefits of these systems, including improved drug permeability, controlled and sustained release, targeted delivery, reduced syst
APA, Harvard, Vancouver, ISO, and other styles
8

Nelemans, Levi Collin, and Leonid Gurevich. "Drug Delivery with Polymeric Nanocarriers—Cellular Uptake Mechanisms." Materials 13, no. 2 (2020): 366. http://dx.doi.org/10.3390/ma13020366.

Full text
Abstract:
Nanocarrier-based systems hold a promise to become “Dr. Ehrlich’s Magic Bullet” capable of delivering drugs, proteins and genetic materials intact to a specific location in an organism down to subcellular level. The key question, however, how a nanocarrier is internalized by cells and how its intracellular trafficking and the fate in the cell can be controlled remains yet to be answered. In this review we survey drug delivery systems based on various polymeric nanocarriers, their uptake mechanisms, as well as the experimental techniques and common pathway inhibitors applied for internalization
APA, Harvard, Vancouver, ISO, and other styles
9

Gupta, Purnima, Evelyn Garcia, Amrita Sarkar, et al. "Nanoparticle Based Treatment for Cardiovascular Diseases." Cardiovascular & Hematological Disorders-Drug Targets 19, no. 1 (2019): 33–44. http://dx.doi.org/10.2174/1871529x18666180508113253.

Full text
Abstract:
Nanotechnology has gained increased attention for delivering therapeutic agents effectively to the cardiovascular system. Heart targeted nanocarrier based drug delivery is a new, effective and efficacious approach for treating various cardiac related disorders such as atherosclerosis, hypertension, and myocardial infarction. Nanocarrier based drug delivery system circumvents the problems associated with conventional drug delivery systems, including their nonspecificity, severe side effects and damage to the normal cells. Modification of physicochemical properties of nanocarriers such as size,
APA, Harvard, Vancouver, ISO, and other styles
10

Su, Shi, and Peter M. Kang. "Recent Advances in Nanocarrier-Assisted Therapeutics Delivery Systems." Pharmaceutics 12, no. 9 (2020): 837. http://dx.doi.org/10.3390/pharmaceutics12090837.

Full text
Abstract:
Nanotechnologies have attracted increasing attention in their application in medicine, especially in the development of new drug delivery systems. With the help of nano-sized carriers, drugs can reach specific diseased areas, prolonging therapeutic efficacy while decreasing undesired side-effects. In addition, recent nanotechnological advances, such as surface stabilization and stimuli-responsive functionalization have also significantly improved the targeting capacity and therapeutic efficacy of the nanocarrier assisted drug delivery system. In this review, we evaluate recent advances in the
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Nanocarrier systems"

1

Agarwal, Abhiruchi. "Nanocarrier mediated therapies for the gliomas of the brain." Diss., Georgia Institute of Technology, 2011. http://hdl.handle.net/1853/39468.

Full text
Abstract:
Existing methods of treating glioma are not effective for eradicating the disease. Therefore, new and innovative methods of treatment alone or in combination with existing therapies are necessary. Delivery of therapeutic agents through delivery carriers such as liposomes diminishes the harmful effects of the agent in healthy tissues and allows increased accumulation in the tumor. In addition, targeted chemotherapy using liposomes provides the opportunity for further increase in drug accumulation in tumor. However, the current targeting strategies suffer accelerated plasma clearance and are not
APA, Harvard, Vancouver, ISO, and other styles
2

Munson, Jennifer Megan. "Novel nanocarriers for invasive glioma." Diss., Georgia Institute of Technology, 2011. http://hdl.handle.net/1853/41226.

Full text
Abstract:
The invasive nature of glioblastoma (GBM) represents a significant challenge to the standard of care and contributes to poor clinical outcomes. Invasion of tumors into healthy brain restricts chemotherapeutic access and complicates surgical resection. The central hypothesis of the thesis is that an effective anti-invasive agent can enhance the standard chemotherapeutic response in invasive brain tumors. Through a screen of novel compounds, a new anti-invasive small molecule, Imipramine Blue (IB), was identified. This triphenylmethane compound inhibits invasion of highly invasive glioma in vit
APA, Harvard, Vancouver, ISO, and other styles
3

Tang, Jingjie. "Innovative imaging systems and novel drug candidates for cancer therapy." Thesis, Aix-Marseille, 2016. http://www.theses.fr/2016AIXM4021.

Full text
Abstract:
Le cancer est l'une des principales causes de décès dans le monde et reste une maladie difficile à traiter du fait des difficultés de pronostic, du développement rapide de métastases et de la résistance aux médicaments. Il en résulte une forte demande en méthodologies d'imagerie innovantes pour le diagnostic précoce et précis ainsi qu’en nouveaux agents anticancéreux possédant de nouveaux mécanismes pour surmonter la résistance aux médicaments. Le but de mon projet de recherche de doctorat était donc de contribuer à cet objectif.La première partie de ma thèse de doctorat a porté sur la créatio
APA, Harvard, Vancouver, ISO, and other styles
4

Tang, Jingjie. "Innovative imaging systems and novel drug candidates for cancer therapy." Electronic Thesis or Diss., Aix-Marseille, 2016. http://www.theses.fr/2016AIXM4021.

Full text
Abstract:
Le cancer est l'une des principales causes de décès dans le monde et reste une maladie difficile à traiter du fait des difficultés de pronostic, du développement rapide de métastases et de la résistance aux médicaments. Il en résulte une forte demande en méthodologies d'imagerie innovantes pour le diagnostic précoce et précis ainsi qu’en nouveaux agents anticancéreux possédant de nouveaux mécanismes pour surmonter la résistance aux médicaments. Le but de mon projet de recherche de doctorat était donc de contribuer à cet objectif.La première partie de ma thèse de doctorat a porté sur la créatio
APA, Harvard, Vancouver, ISO, and other styles
5

Fehse, Susanne [Verfasser]. "Charakterisierung von Cu/Nanocarrier-Komplexen im zellulären System / Susanne Fehse." Berlin : Freie Universität Berlin, 2015. http://d-nb.info/1077211937/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Mishra, Kaushik. "Folate Receptor-Targeted Polymeric Micellar Nanocarriers as Drug Delivery Systems." University of Akron / OhioLINK, 2021. http://rave.ohiolink.edu/etdc/view?acc_num=akron1629218263972419.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Singh, Manu Smriti [Verfasser]. "Nanocarrier system for overcoming multidrug resistance in cancer / Manu Smriti Singh." Bonn : Universitäts- und Landesbibliothek Bonn, 2015. http://d-nb.info/1077289200/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Kurniasih, Indah Nurita [Verfasser]. "Nanocarrier System for Drug Delivery Based on Hyperbranched Polyglycerol / Indah Nurita Kurniasih." Berlin : Freie Universität Berlin, 2013. http://d-nb.info/1043957863/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Santos, João Miguel Almeida. "Gene therapy: development of a new nanocarrier system for mitochondrial gene therapy." Master's thesis, Universidade da Beira Interior, 2013. http://hdl.handle.net/10400.6/1627.

Full text
Abstract:
Mitochondria are unique organelles that have their own genome, the mitochondrial DNA (mtDNA). Although quite small compared to nuclear DNA (nDNA), mutations in mtDNA are quite frequent due to the lack of protection and repair mechanisms. Per consequence, cytopathies and diseases are quite common and mostly associated with high energy demanding tissues such as muscles and the brain. Therefore, the development of a new and efficient mitochondrial gene therapy protocol is seen as a promising approach. During this MSc thesis we try to bring together a new nanocarrier system with the ability
APA, Harvard, Vancouver, ISO, and other styles
10

Saeidpour, Siavash [Verfasser]. "Investigation of nanocarriers as drug delivery systems by electron paramagnetic resonance spectroscopy / Siavash Saeidpour." Berlin : Freie Universität Berlin, 2020. http://d-nb.info/1214241174/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Nanocarrier systems"

1

Shah, Nirmal, ed. Nanocarriers: Drug Delivery System. Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-33-4497-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Jimenez, Carlos. Nanocarrier Systems for Drug Delivery. Nova Science Publishers, Incorporated, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Nanocarrier Drug Delivery Systems: Therapeutic and Diagnostic Medicine. de Gruyter GmbH, Walter, 2024.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Nanocarrier Drug Delivery Systems: Therapeutic and Diagnostic Medicine. de Gruyter GmbH, Walter, 2024.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Nanocarrier Drug Delivery Systems: Therapeutic and Diagnostic Medicine. de Gruyter GmbH, Walter, 2024.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Torchilin, V. P. Smart Pharmaceutical Nanocarriers. Imperial College Press, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Sharma, Anil K., Raj K. Keservani, and Rajesh Kumar Kesharwani. Nanocarriers for Brain Targeting. Taylor & Francis Group, 2021.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Barkat, Md Abul. Multifunctional Nanocarriers for Contemporary Healthcare Applications. IGI Global, 2018.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Keservani, Raj. Nanoconjugate Nanocarriers for Drug Delivery. Apple Academic Press, Incorporated, 2018.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Sharma, Anil K., and Raj K. Keservani. Nanoconjugate Nanocarriers for Drug Delivery. Taylor & Francis Group, 2021.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Nanocarrier systems"

1

Patel, Girishchandra B., and Wangxue Chen. "Archaeosomes as Drug and Vaccine Nanodelivery Systems." In Nanocarrier Technologies. Springer Netherlands, 2006. http://dx.doi.org/10.1007/978-1-4020-5041-1_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Baran, E. Turker, and Rui L. Reis. "Biomimetic Approach to Drug Delivery and Optimization of Nanocarrier Systems." In Nanocarrier Technologies. Springer Netherlands, 2006. http://dx.doi.org/10.1007/978-1-4020-5041-1_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Elkady, Ashraf S., and Renat I. Zhdanov. "Dicationic DEGA-Based Lipid Systems for Gene Transfer and Delivery: Supramolecular Structure and Activity." In Nanocarrier Technologies. Springer Netherlands, 2006. http://dx.doi.org/10.1007/978-1-4020-5041-1_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Iyire, Affiong, Edidiong M. Udofa, Onyinyechi Udo-Chijioke, and Eman Z. Dahmash. "Niosomes as nanocarrier systems in cosmetics." In Nanocosmetics Delivery Approaches, Applications and Regulatory Aspects. CRC Press, 2023. http://dx.doi.org/10.1201/9781003319146-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Rehman, Nahid, and Anjana Pandey. "Nanocarrier Used in Drug Delivery System." In Engineered Nanoparticles as Drug Delivery Systems. CRC Press, 2022. http://dx.doi.org/10.1201/9781003252122-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Le, Ngoc Thuy Trang, Linh Phuong Tran Pham, Diem Huong Tran Nguyen, et al. "Liposome-Based Nanocarrier System for Phytoconstituents." In Novel Drug Delivery Systems for Phytoconstituents. CRC Press, 2019. http://dx.doi.org/10.1201/9781351057639-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Li, Hao, Masaharu Somiya, Kenji Tatematsu, and Shun’ichi Kuroda. "Construction of a Macrophage-Targeting Bio-nanocapsule-Based Nanocarrier." In Drug Delivery Systems. Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4939-9798-5_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Arachchige, Sathika G. G., Ryan Rienzie, and Nadeesh M. Adassooriya. "Nanocarrier-Mediated Drug Delivery Systems for Neurodegenerative Diseases." In Nanobiotechnology in Neurodegenerative Diseases. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-30930-5_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Samrot, Antony V., N. Shobana, Shree S. Krithika, D. Rajalakshmi, M. Sathiyasree, and Preeth R. Sanjay. "Nanocarrier Systems for Delivering Plant-Based Anticancer Agents." In Advances in Phytonanotechnology for Treatment of Various Diseases. CRC Press, 2023. http://dx.doi.org/10.1201/9781003231721-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Patel, Geeta, Bhupendra Prajapati, and Hetal Hinglajia. "Lipid-Based Drug Delivery System: Spotlight on Nanoemulsion as Versatile Nanocarrier." In Lipid-Based Drug Delivery Systems. Jenny Stanford Publishing, 2023. http://dx.doi.org/10.1201/9781003459811-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Nanocarrier systems"

1

Akel, Hussein, and Ildikó Csóka. "Nanocarrier Based Systems for Nose to Brain delivery of Anti-Neurodegenerative Medicines." In I. Symposium of Young Researchers on Pharmaceutical Technology,Biotechnology and Regulatory Science. Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Faculty of Pharmacy, 2019. http://dx.doi.org/10.14232/syrptbrs.2019.op6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Sahu, Ravish, Ashok Kumar, Neeraj Sharma, and Lopa Pradhan. "Role of polymers in novel vesicular nanocarrier systems for treatment of atopic dermatitis: A review." In 14TH INTERNATIONAL CONFERENCE ON MATERIALS PROCESSING AND CHARACTERIZATION 2023. AIP Publishing, 2024. http://dx.doi.org/10.1063/5.0196324.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ismail, Ruba, and Ildikó Csóka. "Quality by Design driven development of Liraglutide loaded nanocarrier system designed for oral delivery." In I. Symposium of Young Researchers on Pharmaceutical Technology,Biotechnology and Regulatory Science. Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Faculty of Pharmacy, 2019. http://dx.doi.org/10.14232/syrptbrs.2019.op18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

T, Aiswarya, Małgorzata Krok-Borkowicz, Kalpana Devi P, and K. K. Singh. "Adsorption and Thermodynamic Behaviour of Fluorographene with Melphalan Drug as Nanocarrier for Drug Delivery System." In The 9th World Congress on Recent Advances in Nanotechnology. Avestia Publishing, 2024. http://dx.doi.org/10.11159/icnnfc24.143.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Karim, Reatul, Farhana Rizwan, Md Mahbubur Rahman Tanim, and Sabrin Islam Khan. "Comparing in vitro Permeability of a Nanocarrier-Hydrogel Hybrid System with an Alcoholic Hydrogel for Sustained Transdermal Drug Delivery." In The 7th World Congress on Recent Advances in Nanotechnology. Avestia Publishing, 2022. http://dx.doi.org/10.11159/nddte22.132.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Saeednia, L., and R. Asmatulu. "Methotrexate Loaded Magnetic Nanoparticles as a Targeted Drug Delivery Device." In ASME 2015 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2015. http://dx.doi.org/10.1115/imece2015-51193.

Full text
Abstract:
Targeted drug delivery systems have been shown to be promising alternative for the conventional drug delivery methods. Among numerous nanocarriers developed for therapeutic applications, iron oxide magnetic nanoparticles have attracted considerable attention. Fe3O4 (magnetite) is one of the most commonly used iron oxide in biomedical applications due to its biocompatibility and can be easily produced in research and industrial laboratories. The core/shell structure of magnetic nanoparticles allows the surface coating to avoid their agglomeration. Moreover, coating of Fe3O4 nanoparticles provid
APA, Harvard, Vancouver, ISO, and other styles
7

Piolo, Kryzel Maire E., Cristella Andrea J. Samonte, Carlo S. Emolaga, and Jeremiah C. Millare. "Comparison of Organic and Inorganic - Modified Halloysite Nanotube for Improved Drug Delivery of Aspirin." In 2023 7th International Conference on Nanomaterials and Biomaterials & 2023 5th Asia Conference on Material and Manufacturing Technology. Trans Tech Publications Ltd, 2024. http://dx.doi.org/10.4028/p-h0cjwf.

Full text
Abstract:
Halloysite nanotubes (HNTs), the naturally formed mineral clays with hollow tubular structures, have found promising applications as nanocarriers for drug delivery systems due to their biocompatibility and nontoxicity. By modifying the lumen of HNT, drug delivery of various types of sensitive and low-dissolution drugs could be enhanced. This study presents a comparison of the properties of modified HNTs containing an organic modifier (Sodium Laureth Sulfate, SLES) and an inorganic modifier (Sodium Thiosulfate, STS) as carriers of a slightly water-soluble drug, aspirin. HNTs modified by STS sho
APA, Harvard, Vancouver, ISO, and other styles
8

Baccile, Niki, Alexandre Poirier, and Chloe Seyrig. "Biosurfactants and biopolymers: Between interactions, orthogonality and mutual responsivity." In 2022 AOCS Annual Meeting & Expo. American Oil Chemists' Society (AOCS), 2022. http://dx.doi.org/10.21748/taly8346.

Full text
Abstract:
Polymer-surfactant systems have many applications in everyday life, but their petrochemical origin is not only controversial but soon submitted to regulatory restrictions. In a more environmentally friendly approach, but also to forecast regulations in both EU and USA, biopolymer-biosurfactant systems are an interesting alternative. There exists a large family of both biobased surfactants and polymers, which possess a huge potential, however currently limited, because both the solution behaviour of the former and their interactions are not established, yet. [1] This presentation shows the firs
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Nanocarrier systems' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography